The potential value of Clostridium difficile vaccine: an economic computer simulation model

Area of Science:

• Infectious Diseases
• Vaccinology
• Health Economics

Background:

• Clostridium difficile infection (CDI) poses a significant public health challenge.
• Current efforts focus on developing effective vaccines to combat CDI.
• Preventing primary and recurrent CDI is a key therapeutic goal.

Purpose of the Study:

• To evaluate the cost-effectiveness of a potential Clostridium difficile vaccine.
• To model the economic impact of CDI vaccine administration for initial prevention.
• To assess the economic viability of using a CDI vaccine for recurrence prevention.

Main Methods:

• Development of two decision analytic Monte Carlo computer simulation models.
• Initial Prevention Model: Assesses vaccine administration for at-risk patients.
• Recurrence Prevention Model: Evaluates vaccine use post-CDI treatment to prevent recurrence.

Main Results:

• A Clostridium difficile vaccine demonstrates potential cost-effectiveness.
• Cost-effectiveness is observed across a broad spectrum of CDI risk.
• Vaccine cost and efficacy significantly influence cost-effectiveness, particularly for recurrence prevention.

Conclusions:

• A Clostridium difficile vaccine is likely a cost-effective intervention.
• The vaccine is especially promising for preventing recurrent CDI.
• Economic viability supports further development and implementation of CDI vaccines.